PUBLIC COMPANY
saveBoehringer Ingelheim International GmbH
updated 2mo ago
community read0 votes
🐶 often sniffed alongside
top 7pipeline
11
marketed
2
phase 3
4
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(11)
pipeline depth11 products
4Phase 24Phase 32Marketed1Unknown
Marketed
nerandomilast
Systemic Sclerosis (Scleroderma)
Marketedspesolimab
Pyoderma Gangrenosum
IL36 receptor
Phase 3empagliflozin
Diastolic Heart Failure (HFpEF)
Sodium/glucose cotransporter 2
Phase 3survodutide
Liver Fibrosis
Glucagon-like peptide 1 receptorGlucagon receptor
Phase 3verducatib
Bronchiectasis
Phase 3vicadrostat
Diastolic Heart Failure (HFpEF)
Phase 2BI-1819479
Idiopathic Pulmonary Fibrosis
Phase 2BI-836858
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Phase 2avenciguat
Systemic Sclerosis (Scleroderma)
Phase 2obrixtamig
Small-Cell Lung Cancer
drugBI-765179
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that